P1, N=376, Recruiting, Gilead Sciences | N=216 --> 376 | Trial completion date: Feb 2027 --> Dec 2027 | Trial primary completion date: Jun 2026 --> Dec 2027

12 months ago

Enrollment change • Trial completion date • Trial primary completion date • Combination therapy • Metastases

Yutuo (zimberelimab) • denikitug (GS-1811)

almost2years

Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors (clinicaltrials.gov)

P1, N=216, Recruiting, Gilead Sciences | N=158 --> 216 | Trial completion date: Feb 2025 --> Feb 2027 | Trial primary completion date: Feb 2024 --> Jun 2026

almost 2 years ago

Enrollment change • Trial completion date • Trial primary completion date • Combination therapy • Metastases

Yutuo (zimberelimab) • denikitug (GS-1811)